| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tectonic Therapeutic, Inc. (TECX) has 10 insiders with recent SEC Form 4 filings, including 23 buys and 1 sell. TECX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 239.2K | $6.41M | - | |
| Other | 55.3K | $1.48M | - | |
| Other | 40.9K | $1.10M | - | |
| CFO | 28.1K | $754.2K | - | |
| Dir | 10.2K | $273.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | Springer Timothy A49 | Director, 10% Owner | Buy | 141,923 | $16.20 | $2,299,014.65 | +0.6% | +34.4% | +90.1% | |
| Apr 7, 2025 | McGuire Terrance | Director | Sell | 500,000 | $17.10 | $8,550,000.00 | -46.6% | +33.8% | +87.0% | |
| Apr 7, 2025 | Springer Timothy A49 | Director, 10% Owner | Buy | 500,000 | $17.10 | $8,550,000.00 | +9.6% | +33.8% | +87.0% | |
| Feb 5, 2025 | Lochner Daniel | Chief Financial Officer | Buy | 4,617 | $54.14 | $249,964.38 | New | -59.6% | -51.2% | |
| Feb 5, 2025 | Springer Timothy A49 | Director, 10% Owner | Buy | 789,294 | $50.68 | $39,999,977.16 | +17.9% | -59.6% | -51.2% | |
| Oct 22, 2024 | Springer Timothy A49 | Director, 10% Owner | Buy | 300,000 | $33.59 | $10,077,000.00 | +7.9% | +14.0% | -51.3% | |
| Sep 26, 2024 | Springer Timothy A49 | Director, 10% Owner | Buy | 50,000 | $28.82 | $1,440,828.83 | +0.3% | +79.1% | -46.8% | |
| May 14, 2024 | Leonard Braden Michael61 | 10% Owner | Buy | 766,635 | $1.27 | $971,492.88 | +6.0% | +5.6% | +28.6% | |
| Jul 7, 2021 | Vickers Philip J. | Director | Buy | 4,800 | $8.35 | $40,080.00 | New | -36.4% | -87.6% | |
| Feb 17, 2021 | Donenberg Phillip B. | Director | Buy | 2,000 | $11.71 | $23,420.00 | New | - | - |